Եվրոպական Միություն - իտալերեն - EMA (European Medicines Agency)

biopartners gmbh - recombinant human interferon alfa-2a - epatite c, cronica - immunostimolanti, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.

Եվրոպական Միություն - իտալերեն - EMA (European Medicines Agency)

virbac s.a. - interferone omega ricombinante di origine felina - immunostimolanti, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. nei gatti infetti da fiv, la mortalità era bassa (5%) e non era influenzata dal trattamento.

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - peginterferonum alfa-2a - soluzione iniettabile in flaconcino - peginterferonum alfa-2a 180 µg, natrii chloridum, alcohol benzylicus 10 mg, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, natrii acetas trihydricus aut acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.6 mg. - chronische epatite b, chronische epatite c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - 5 ml, fertigspritzen - peginterferonum alfa-2a 135 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - chronische hepatitis b; chronische hepatitis c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - 5 ml, fertigspritzen - peginterferonum alfa-2a 180 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - chronische hepatitis b; chronische hepatitis c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - injektionslösung in der durchstechflasche - peginterferonum alfa-2a 135 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 10 mg, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. - chronische hepatitis b, chronische hepatitis c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - 5 ml, fertigpen - peginterferonum alfa-2a 135 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - chronische hepatitis b, chronische hepatitis c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - 5 ml, fertigpen - peginterferonum alfa-2a 180 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - chronische hepatitis b, chronische hepatitis c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - 5 ml, injektionslösung in fertigspritzen - peginterferonum alfa-2a 135 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - chronische hepatitis b; chronische hepatitis c - biotechnologika

Շվեյցարիա - իտալերեն - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - peginterferonum alfa-2a - 5 ml, injektionslösung in fertigspritzen - peginterferonum alfa-2a 180 µg, natrii chloridum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, conserv.: alcohol benzylicus 5 mg, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - chronische hepatitis b; chronische hepatitis c - biotechnologika